Possible scenario
Governance And IP
20% Chance
Because the atlas involves human brain biology, regulators, universities, and patient-data stewards may scrutinize consent, data provenance, and downstream commercial use. This is less likely than routine adoption but plausible given the rapid expansion of open AI-biology datasets.
Secondary impacts
- Technology -0.1%
- Healthcare -0.1%
Tickers
- RXRX-0.1%
Portfolio impact
S&P 500-0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.